FEMSelect
PrivateLast Round
Series B
Extension
May 13, 2025
Total Funding Raised
$14.3M
Company Overview
FEMSelect operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B Extension round in May 2025.
FEMSelect is a medical technology company that develops minimally invasive surgical systems for the treatment of pelvic organ prolapse.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FEMSelect Comparables
Compare FEMSelect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Escala Medical | 92% | |
| Neomedic International | 82% | |
| Caldera Medical | 80% |
For institutional investors. Book with your work email.
FEMSelect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 13, 2025 | ||||
| Series B | Oct 19, 2022 | ||||
| Series A | Jan 24, 2018 | ||||
| Seed | Dec 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FEMSelect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordwand Capital | Series B Extension |
| TransPacific Venture Partners | Series B |
| Robin Hood Ventures | Series B Extension, Series B |
| Keiretsu Capital | Series B |
| MEDA Angels | Series B |
| Keiretsu Forum Mid-Atlantic | Series B |
| Triventures | Series B Extension, Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 41% MoM.
- Jun 6, 2025
Grew 25% QoQ from 12 to 15 employees.
For institutional investors. Book with your work email.
FEMSelect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FEMSelect's valuation, stock price, and market status.
Is FEMSelect a public or private company?
FEMSelect is a private company.
What is the current stock price of FEMSelect?
FEMSelect is a private company, so its shares have no public market price. Caplight tracks FEMSelect's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FEMSelect worth (valuation)?
Valuation information for FEMSelect is not publicly available.
Can I buy FEMSelect stock?
FEMSelect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FEMSelect's last funding round?
FEMSelect's most recent funding round was Series B Extension on May 13, 2025.
Who are the main investors in FEMSelect?
Key investors in FEMSelect include Triventures, New Age Ventures, RAD BioMed.
Will FEMSelect IPO soon?
No public IPO plans have been announced for FEMSelect.
How can I track FEMSelect secondary market activity?
Caplight tracks bids, offers, and trades in FEMSelect's shares on secondary markets.